CAPRICOR THERAPEUTICS
US stocks: Capricor shares 77% soar as potential FDA lifeline revives Duchenne drug hopesCapricor Therapeutics shares surged significantly after the FDA agreed to review new drug data. The company had faced setbacks last month r...
Silver price streak turns historic — 8 straight green months could match its legendary 1980 runSilver is experiencing a historic rally, outperforming gold with significant gains. Strong investor interest, limited supply from mines, an...
CAPR stock price: Why is Capricor Therapeutics stock surging over 293% today?CAPR stock: Capricor Therapeutics' stock soared over 293% after its Phase 3 HOPE-3 trial for Duchenne muscular dystrophy showed promising r...
- Load More